What’s Vulnerable › Vulnerabilities
CVE-2022-45611
- Severity: critical (CVSS 9.8 v3.1)
- Exploited in the wild: not listed in CISA KEV
- EPSS: 1.2% probability of exploitation in the next 30 days
- Public exploit or detection template: none known
- Published: 2023-08-22 · updated 2026-06-17
- Weakness: CWE-522
Description
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Affected products
- Fresenius-Kabi Pharmahelp Firmware: 5.1.759.0
References
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
Get alerted when CVE-2022-45611 or the next vulnerability affects your stack